These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 14678236)

  • 1. Direct vascular effects of HR780, a novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
    Wajima T; Makita S; Oshima K
    Clin Exp Pharmacol Physiol; 2003 Dec; 30(12):958-62. PubMed ID: 14678236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carvastatin suppresses intimal thickening of rabbit carotid artery after balloon catheter injury probably through the inhibition of vascular smooth muscle cell proliferation and migration.
    Komukai M; Wajima YS; Tashiro J; Shinomiya M; Saito Y; Morisaki N
    Scand J Clin Lab Invest; 1999 May; 59(3):159-66. PubMed ID: 10400160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cultured vascular smooth muscle cell migration by simvastatin (MK-733).
    Hidaka Y; Eda T; Yonemoto M; Kamei T
    Atherosclerosis; 1992 Jul; 95(1):87-94. PubMed ID: 1642695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMG-CoA reductase inhibitors prevent migration of human coronary smooth muscle cells through suppression of increase in oxidative stress.
    Yasunari K; Maeda K; Minami M; Yoshikawa J
    Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):937-42. PubMed ID: 11397700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of migration and proliferation of rat vascular smooth muscle cells by a new HMG-CoA reductase inhibitor, pitavastatin.
    Kohno M; Shinomiya K; Abe S; Noma T; Kondo I; Oshita A; Takeuchi H; Takagi Y; Yukiiri K; Mizushige K; Ohmori K
    Hypertens Res; 2002 Mar; 25(2):279-85. PubMed ID: 12047044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase.
    Corsini A; Mazzotti M; Raiteri M; Soma MR; Gabbiani G; Fumagalli R; Paoletti R
    Atherosclerosis; 1993 Jun; 101(1):117-25. PubMed ID: 8216498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1).
    Laufs U; Marra D; Node K; Liao JK
    J Biol Chem; 1999 Jul; 274(31):21926-31. PubMed ID: 10419514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of HMG-CoA reductase inhibitors on extracellular matrix expression in human vascular smooth muscle cells.
    Riessen R; Axel DI; Fenchel M; Herzog UU; Rossmann H; Karsch KR
    Basic Res Cardiol; 1999 Oct; 94(5):322-32. PubMed ID: 10543307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins.
    Yang Z; Kozai T; van der Loo B; Viswambharan H; Lachat M; Turina MI; Malinski T; Lüscher TF
    J Am Coll Cardiol; 2000 Nov; 36(5):1691-7. PubMed ID: 11079678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cerivastatin on human arterial smooth muscle cell proliferation and migration in transfilter cocultures.
    Axel DI; Riessen R; Runge H; Viebahn R; Karsch KR
    J Cardiovasc Pharmacol; 2000 Apr; 35(4):619-29. PubMed ID: 10774794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of pravastatin, simvastatin, and atorvastatin on Ca2+ release and vascular reactivity.
    Tesfamariam B; Frohlich BH; Gregg RE
    J Cardiovasc Pharmacol; 1999 Jul; 34(1):95-101. PubMed ID: 10413074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of atherosclerosis and the role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Corsini A; Raiteri M; Soma MR; Bernini F; Fumagalli R; Paoletti R
    Am J Cardiol; 1995 Jul; 76(2):21A-28A. PubMed ID: 7604791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-lipid-related effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Corsini A; Bernini F; Quarato P; Donetti E; Bellosta S; Fumagalli R; Paoletti R; Soma VM
    Cardiology; 1996; 87(6):458-68. PubMed ID: 8904671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of fluvastatin on growth of porcine and human vascular smooth muscle cells in vitro.
    Rogler G; Lackner KJ; Schmitz G
    Am J Cardiol; 1995 Jul; 76(2):114A-116A. PubMed ID: 7604784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of HR780, a novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in Watanabe heritable hyperlipidemic rabbits and cholesterol-fed rabbits.
    Wajima T; Makita S; Oshima K
    Pharmacology; 2004 Mar; 70(3):123-9. PubMed ID: 14752232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin, a potent HMG-CoA reductase inhibitor, inhibits the proliferation of human and bovine endothelial cells in vitro.
    Sato I; Ma L; Ikeda M; Morita I; Murota S
    J Atheroscler Thromb; 1998; 4(3):102-6. PubMed ID: 9730140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK-104, a newly developed HMG-CoA reductase inhibitor, suppresses neointimal thickening by inhibiting smooth muscle cell growth and fibronectin production in balloon-injured rabbit carotid artery.
    Kitahara M; Kanaki T; Toyoda K; Miyakoshi C; Tanaka S; Tamaki T; Saito Y
    Jpn J Pharmacol; 1998 Jun; 77(2):117-28. PubMed ID: 9681568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the effects of HMG-CoA reductase inhibitors on proliferation and viability of smooth muscle cells in culture.
    Sindermann JR; Fan L; Weigel KA; Troyer D; Müller JG; Schmidt A; March KL; Breithardt G
    Atherosclerosis; 2000 Jun; 150(2):331-41. PubMed ID: 10856525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration.
    Porter KE; Naik J; Turner NA; Dickinson T; Thompson MM; London NJ
    J Vasc Surg; 2002 Jul; 36(1):150-7. PubMed ID: 12096273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of neointimal thickening by a newly developed HMG-CoA reductase inhibitor, BAYw6228, and its inhibitory effect on vascular smooth muscle cell growth.
    Igarashi M; Takeda Y; Mori S; Ishibashi N; Komatsu E; Takahashi K; Fuse T; Yamamura M; Kubo K; Sugiyama Y; Saito Y
    Br J Pharmacol; 1997 Mar; 120(6):1172-8. PubMed ID: 9134232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.